Author

N. W. Fowlkes

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Approach:experimental assay· 3 Organism:mouse· 2 Organism:human· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

D. Marin· 2 shared E. Gokdemir· 2 shared E. Liu· 2 shared G. Ozcan· 2 shared H. Shaim· 2 shared J. Lu· 2 shared K. Chen· 2 shared K. Rezvani· 2 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

D. Marin

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintFeb 1, 2023

Antitumor activity of intraperitoneal paclitaxel in orthotopic patient-derived xenograft models of mucinous appendiceal adenocarcinoma

I. Ito, P. N. Dickson, A. M. Yousef…·J. P. Shen

This study evaluates the antitumor effect of intraperitoneal paclitaxel in orthotopic patient-derived xenograft models of mucinous appendiceal adenocarcinoma, showing significant tumor growth reduction.

DOI 10.1101/2023.02.01.526672

mouseexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintMar 30, 2020

Inhibition of the av integrin-TGF-b axis improves natural killer cell function against glioblastoma stem cells

H. Shaim, M. Hernandez Sanabria, R. Basar…·K. Rezvani

The paper shows that inhibiting the integrin-TGF-β axis enhances NK cell function against glioblastoma stem cells, suggesting it as a therapeutic target.

DOI 10.1101/2020.03.30.016667

humanscRNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintMar 29, 2020

CIS checkpoint deletion enhances the fitness of cord blood derived natural killer cells transduced with a chimeric antigen receptor

K. Rezvani, M. Daher, R. Basar…·Wei Inn

This paper combines CIS checkpoint deletion with CAR engineering in NK cells to enhance their metabolic fitness and anti-tumor activity in a lymphoma model.

DOI 10.1101/2020.03.29.014472

mouseproteomics

𝕏 PostBluesky